PDCD5P1

Across TCGA pan-cancer cohorts, PDCD5P1 RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated PDCD5P1 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher PDCD5P1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated PDCD5P1 expression acts as an unfavorable survival marker, although some lineages such as LUSC and THCA show a favorable association.

MESO, STAD, and LUSC are the cancer types where PDCD5P1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	DFS	Tertile	All	0.242	0.462	<.001	72	view →
STAD	OS	Median	All	0.625	0.744	.005	57	view →
LUSC	OS	Median	II,III,IV	0.494	0.271	<.001	49	view →
LIHC	DFS	Quartile	All	0.455	0.664	.001	40	view →
KICH	DFS	Quartile	III,IV	0.047	1.000	.005	37	view →
BRCA	DFS	Median	IV	0.323	0.746	.005	31	view →
CHOL	DFS	Tertile	All	0.088	0.553	.004	28	view →
THCA	DFS	Median	III,IV	0.864	0.250	.004	27	view →
KIRP	OS	Median	All	0.604	0.755	.006	26	view →
CESC	DFS	Median	II,III,IV	0.884	0.682	.005	18	view →
THYM	DFS	Quartile	III,IV	0.438	1.000	.017	12	view →
KIRC	DFS	Tertile	IV	0.495	0.699	.011	10	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 25 lineages.

PDCD5P1–MESO (DFS)

Open the MESO breakdown →